MedNexus
2019年 · 第132卷第23期
出版日期 2019-12-05电子版 ￥0.00元
MedNexus
- 全部
- Editorial
- Original Article
- Study Protocol
- Review Article
- Clinical Observation
- Correspondence
Editorial
开放获取
采取行动弥合中国与其他国家之间的差距：在中国透析结果和实践模式研究第5阶段的矿质骨病标志物方面Li Zhou, Ping Fu
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000497
摘要
中国国家肾脏数据系统[
Original Article
开放获取
中国透析结果和实践模式研究中的矿物质和骨疾病及其管理Jun Wang, Brian A. Bieber, Fan-Fan Hou, Friedrich K. Port, Shuchi Anand
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000533
摘要
Background:
Despite a growing population of patients starting hemodialysis in China, little is known about markers of mineral bone disease (MBD) and their management. We present data on prevalence and correlates of hypocalcemia, hyperphosphatemia, and secondary hyperparathyroidism from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), with evaluation of whether these laboratory markers triggered changes in management.
Methods:
We compared the frequency of measurement and prevalence of poor control of MBD markers in China DOPPS with other DOPPS regions. We also used generalized estimating equations to assess correlates of MBD markers, and separate models to assess predictors of vitamin D and phosphate binder prescriptions in the China DOPPS.
Results:
Severe hyperphosphatemia (>7 mg/dL) and secondary hyperparathyroidism (>600 pg/mL) were common (27% and 21% prevalence, respectively); both were measured infrequently (14.9% and 3.2% of patients received monthly measurements in China). Frequency of dialysis sessions was positively associated with hyperphosphatemia; presence of residual kidney function was negatively associated with both hyperphosphatemia and secondary hyperparathyroidism. Laboratory measures indicating poor control of MBD were not associated with subsequent prescription of active vitamin D or phosphate binder.
Conclusions:
There are substantial opportunities for improvement and standardization of MBD management in China. Development of country-specific guidelines may yield realistic targets and standardization of medication use accounting for availability and cost.
开放获取
2015年至2018年中国肺移植Chun-Xiao Hu, Wen-Hui Chen, Jian-Xing He, Ge-Ning Jiang, Xiao-Shan Li, Dong Wei, Bo Wu, Ji Zhang, Chen Wang, Jing-Yu Chen
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000543
摘要
Background:
Lung transplantation (LT) has been demonstrated as the only effective therapy for patients with end-stage lung diseases. Increasing listed lung transplant candidates and expanding volumes of lung transplant centers across China require wellorganized programs and registry data collection based on the large population. This study aimed to summarize and analyze the data of LT development in China.
Methods:
We retrospectively collected and analyzed data from the China Lung Transplantation Registry (CLuTR). Key data were reported from the registry with transplant types, indications, donor and recipient characteristics, outcomes and survival. The survival <30 days, 1-year and 3-year survival rates were estimated with risk factors identified.
Results:
CLuTR contained data from 1053 lung transplants performed through January 1st, 2015 to December 31st, 2018 reported by 18 registered transplant centers. The largest category of diagnosis before transplantation was idiopathic interstitial pneumonitis. The total <30 days, 1-year and 3-year survival rates in CLuTR were 81.45%, 70.11%, and 61.16% with discrepancy by indications. Large proportion of recipients who were more than 60 years old required higher standard of care. Infection-related complications resulted in more death events in the early post-surgery periods. New York Heart Association grading at listing, extra-corporeal membrane oxygenation usage peri-transplantation, allograft dysfunction (primary graft dysfunction >Grade 0), renal insufficiency (estimated glomerular filtration rate <60 mL·min–1·1.73 m–2), were independently associated with a higher risk for 3-year mortality in the entire cohort.
Conclusions:
Facing more end-stage of lung diseases and comorbidities, this study analyzed the outcomes and survival of LT recipients in China. Further prospectively stratified analyses with longer follow-up will be needed.
开放获取
阿替珠单抗联合化疗治疗广泛小细胞肺癌的成本—效果分析Ling-Yu Li, Hong Wang, Xiao Chen, Wen-Qian Li, Jiu-Wei Cui
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000536
摘要
Background:
IMpower 133 trial first confirmed the efficacy and safety of adding atezolizumab or placebo to first-line treatment with chemotherapy in patients with extensive-stage small-cell lung cancer (SCLC). While, overprice limited its broad use in clinical. The aim of this study was to evaluate the cost-effectiveness of atezolizumab plus chemotherapy in treatment of extensive SCLC as first line in China.
Methods:
A Markov model was established by extracting data from the IMpower 133 trial with untreated extensive SCLC patients. Utility values were obtained from published studies, and the costs were acquired from real world and literature. Additionally, sensitivity analyses based on a willingness-to-pay (WTP) threshold were performed to identify the uncertain parameters of Markov model.
Results:
Total costs of atezolizumab group were $48,129, while cost of chemotherapy alone was just $12,920 in placebo group. The quality-adjusted life-years (QALYs) in atezolizumab group was just 0.072 higher than that in placebo group (0.858 QALYs vs. 0.786 QALYs). The cost-effectiveness ratio between atezolizumab combination with chemotherapy and chemotherapy alone was $489,013/QALY in China. The net benefit of placebo group was significantly higher than atezolizumab group. One-way sensitivity analyses highlighted that utilities of the progression-free survival (PFS) and progression disease state in placebo group were the most influential parameter.
Conclusions:
Atezolizumab combination therapy was not more cost-effective than chemotherapy alone at a WTP threshold of $25,929/QALY in China.
开放获取
基于更快区域的卷积神经网络胰腺癌人工智能诊断系统的建立与应用Shang-Long Liu, Shuo Li, Yu-Ting Guo, Yun-Peng Zhou, Zheng-Dong Zhang, Shuai Li, Yun Lu
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000544
摘要
Background:
Early diagnosis and accurate staging are important to improve the cure rate and prognosis for pancreatic cancer. This study was performed to develop an automatic and accurate imaging processing technique system, allowing this system to read computed tomography (CT) images correctly and make diagnosis of pancreatic cancer faster.
Methods:
The establishment of the artificial intelligence (AI) system for pancreatic cancer diagnosis based on sequential contrastenhanced CT images were composed of two processes: training and verification. During training process, our study used all 4385 CT images from 238 pancreatic cancer patients in the database as the training data set. Additionally, we used VGG16, which was pretrained in ImageNet and contained 13 convolutional layers and three fully connected layers, to initialize the feature extraction network. In the verification experiment, we used sequential clinical CT images from 238 pancreatic cancer patients as our experimental data and input these data into the faster region-based convolution network (Faster R-CNN) model that had completed training. Totally, 1699 images from 100 pancreatic cancer patients were included for clinical verification.
Results:
A total of 338 patients with pancreatic cancer were included in the study. The clinical characteristics (sex, age, tumor location, differentiation grade, and tumor-node-metastasis stage) between the two training and verification groups were insignificant. The mean average precision was 0.7664, indicating a good training effect of the Faster R-CNN. Sequential contrastenhanced CT images of 100 pancreatic cancer patients were used for clinical verification. The area under the receiver operating characteristic curve calculated according to the trapezoidal rule was 0.9632. It took approximately 0.2 s for the Faster R-CNN AI to automatically process one CT image, which is much faster than the time required for diagnosis by an imaging specialist.
Conclusions:
Faster R-CNN AI is an effective and objective method with high accuracy for the diagnosis of pancreatic cancer.
Trial Registration:
ChiCTR1800017542; http://www.chictr.org.cn.
开放获取
深度神经网络辅助CT诊断胃癌转移淋巴结Yuan Gao, Zheng-Dong Zhang, Shuo Li, Yu-Ting Guo, Qing-Yao Wu, Shu-Hao Liu, Shu-Jian Yang, Lei Ding, Bao-Chun Zhao, Shuai Li 等
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000532
摘要
Background:
Artificial intelligence-assisted image recognition technology is currently able to detect the target area of an image and fetch information to make classifications according to target features. This study aimed to use deep neural networks for computed tomography (CT) diagnosis of perigastric metastatic lymph nodes (PGMLNs) to simulate the recognition of lymph nodes by radiologists, and to acquire more accurate identification results.
Methods:
A total of 1371 images of suspected lymph node metastasis from enhanced abdominal CT scans were identified and labeled by radiologists and were used with 18,780 original images for faster region-based convolutional neural networks (FR-CNN) deep learning. The identification results of 6000 random CT images from 100 gastric cancer patients by the FR-CNN were compared with results obtained from radiologists in terms of their identification accuracy. Similarly, 1004 CT images with metastatic lymph nodes that had been post-operatively confirmed by pathological examination and 11,340 original images were used in the identification and learning processes described above. The same 6000 gastric cancer CT images were used for the verification, according to which the diagnosis results were analyzed.
Results:
In the initial group, precision-recall curves were generated based on the precision rates, the recall rates of nodule classes of the training set and the validation set; the mean average precision (mAP) value was 0.5019. To verify the results of the initial learning group, the receiver operating characteristic curves was generated, and the corresponding area under the curve (AUC) value was calculated as 0.8995. After the second phase of precise learning, all the indicators were improved, and the mAP and AUC values were 0.7801 and 0.9541, respectively.
Conclusion:
Through deep learning, FR-CNN achieved high judgment effectiveness and recognition accuracy for CT diagnosis of PGMLNs.
Trial Registration:
Chinese Clinical Trial Registry, No. ChiCTR1800016787; http://www.chictr.org.cn/showproj.aspx?proj= 28515.
开放获取
分层疼痛管理咨询和实施提高患者满意度：一项前瞻性试点研究Li-Hua Peng, Su Min, Ju-Ying Jin, Wen-Jian Wang
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000540
摘要
Background:
Post-operative pain is unpleasant for patients and may worsen surgical recovery. Peri-operative multimodal analgesia has been used for many years; however, its efficacy still needs improvement. In the present study, a thorough peri-operative pain counseling and stratified management program based on risk assessment was implemented, with the goal of improving postoperative analgesia and patient satisfaction.
Methods:
This prospective, controlled, pilot study included 361 patients who underwent elective surgery. Of these 361 patients, 187 received peri-operative pain risk assessment and stratified analgesia and counseling (stratified analgesia group), while 174 received conventional multimodal analgesia (conventional group). The two groups were compared regarding the post-operative pain intensity, rescue analgesia administration, post-operative quality of recovery as assessed via the quality of recovery 40 questionnaire, total dosage of peri-operative opioids, analgesic satisfaction, and analgesic costs.
Results:
Compared with the conventional group, the stratified analgesia group reported decreased pain intensity during motion at 24 h post-operatively and required lower dosages of rescue analgesia (P = 0.03). The total quality of recovery 40 questionnaire score and the scores for physical wellbeing and pain were significantly better in the stratified analgesia group than the conventional group(P = 0.04); the stratified analgesia group also reported better scores for analgesic satisfaction (P = 0.03) and received lower dosages of opioids (P = 0.03). Analgesic costs were lower in the stratified analgesia group than the conventional group; the cost-effective ratio was 109 in the conventional group and 62 in the stratified analgesia group.
Conclusions:
The analgesic efficacy was improved by the implementation of stratified analgesia based on surgical pain risk assessment and counseling. This stratified analgesia protocol increased the patients’ analgesic satisfaction and improved the quality of recovery without increasing healthcare costs. The present findings may help improve the efficacy of peri-operative multimodal analgesia in clinical practice.
Clinical Trial Registry:
NCT02728973; https://clinicaltrials.gov/ct2/show/NCT02728973 ?term=NCT02728973 &draw= 2&rank=1.
开放获取
Crowe I~III型发育不良髋关节髋臼杯部件放置的最佳髋臼骨：计算机模拟研究Lin-Li Zheng, Yang-Yang Lin, Xiao-Yan Zhang, Qian-Hui Ling, Wei-Ming Liao, Pei-Hui Wu
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000527
摘要
Background:
During cup implantation, vertical height of the cup center (V-HCC) should be precisely controlled to achieve sufficient bone-cup coverage (BCC). Our study aimed to investigate the acetabular bone stock and the quantitative relationship between V-HCC and BCC in Crowe types I to III hips.
Methods:
From November 2013 to March 2016, pelvic models of 51 patients (61 hips) with hip dysplasia were retrospectively reconstructed using a computer software. Acetabular height and doom thickness were measured on the mid-acetabular coronal cross section. V-HCC was defined as the vertical distance of cup rotational center to the interteardrop line (ITL). In the cup implantation simulation, the cup was placed at the initial preset position, with a V-HCC of 15 mm, and moved proximally by 3-mm increments. At each level, the BCC was automatically calculated by computer. Analysis of variance and Kruskal-Wallis test were used to compare the differences between groups.
Results:
There were no significant between-group differences in maximum thickness of the acetabular doom; however, peak bone stock values were obtained at heights of 41.63 ± 5.14 mm (Crowe type I), 47.58 ± 4.10 mm (Crowe type II), and 55.78 ± 3.64 mm(Crowe type III) above the ITL. At 15 mm of V-HCC, median BCC was 78% (75–83%) (Crowe type I), 74% (66–71%) (Crowe type II), and 61% (57–68%) (Crowe type III). To achieve 80% of the BCC, the median V-HCC was 16.27 (15.00–16.93) mm, 18.19(15.01–21.53) mm, and 24.13 (21.02–28.70) mm for Crowe types I, II, and III hips, respectively.
Conclusion:
During acetabular reconstruction, slightly superior placement with V-HCC <25 mm retained sufficient bone coverage in Crowe I to III hips.
开放获取
脑脊液中内部转录间隔区扩增子的元分类学用于隐球菌性脑膜炎的诊断和基因分型Ji-Ting Zhu, Han Lin, Xuan Wu, Zhi-Wen Li, Ai-Yu Lin
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000541
摘要
Background:
Cryptococcal meningitis is a severe infectious disease associated with high morbidity and mortality. Rapidity and accuracy of diagnosis contribute to better prognosis, but readily available tools, such as microscopy, culture, and antigens do not perform well all the time. Our study attempted to diagnose and genotype cryptococcus in the cerebrospinal fluid (CSF) samples from patients with cryptococcal meningitis using the approach of metataxonomics of Internal Transcribed Spacer (ITS) amplicons.
Methods:
The CSF samples were collected from 11 clinically suspected cryptococcal meningitis patients and four non-infectious controls. Samples were recruited from the First Affiliated Hospital of Fujian Medical University Hospital, Fuzhou Fourth Hospital and the 476th Hospital of Chinese People’s Liberation Army from December 2017 to December 2018. ITS1 ribosomal deoxyribonucleic acid (rDNA) genes of 15 whole samples were amplified by universal forward primer ITS1 (CTTGGTCATTTAGAGGAAGTAA) and reverse primer ITS2 (GCTGCGTTCTTCATCGATGC), sequenced by Illumina MiSeq Benchtop Sequencer. The results were confirmed by sanger sequencing of ITS1 region and partial CAP59 gene of microbial isolates from 11 meningitic samples. Pair-wise comparison between infectious group and control group was conducted through permutational multivariate analysis (PERMANOVA) in R software.
Results:
The 30,000 to 340,000 high-quality clean reads were obtained from each of the positively stained or cultured CSF samples and 8 to 60 reads from each control. The samples from 11 infected patients yielded detectable cryptococcal-specific ITS1 DNA with top abundance (from 95.90% to 99.97%), followed by many other fungal groups (each <1.41%). ITS genotype was defined in 11 CSF samples, corresponding to ITS type 1, and confirmed by Sanger sequencing. A statistically significant difference (r2 = 0.65869, P = 0.0014) between infectious group and control group was observed.
Conclusions:
The metataxonomics of ITS amplicons facilitates the diagnosis and genotype of cryptococcus in CSF samples, which may provide a better diagnostic approach of cryptococcal infection.
开放获取
筛选MYH7肥厚型心肌病基因突变位点及其意义Hui-Ting Liu, Fang-Fang Ji, Ling Wei, An-Jun Zuo, Yu-Xiu Gao, Lin Qi, Bu Jin, Ji-Gang Wang, Peng Zhao
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000428
摘要
Background:
There have been few reports of mutations in the beta-myosin heavy chain (MYH7) gene in hypertrophic cardiomyopathy (HCM), which is associated with sudden cardiac death caused by HCM. This study aimed to screen the mutation sites in the sarcomeric gene MYH7 in Chinese patients with HCM. We also planned to analyze the pathogenicity of the mutation site as well as its significance in clinical and forensic medicine.
Methods:
From January 2006 to June 2017, autopsy cases were collected from the Department of Pathology, the Affiliated Hospital of Qingdao University. The experiment was to detect MYH7 gene status in formalin-fixed paraffin-embedded tissues from 18 independent autopsy cases who suffered HCM related sudden death (fatal HCM) and 20 cases without cardiomyopathy. Common mutation exon fragments of MYH7 gene were amplified by polymerase chain reaction. The end-of-deoxygenation method and gene cloning method were further performed to analyze the mutation sites. Homologous comparison among mutant sites was conducted using BLAST online database.
Results:
The 1336th nucleotide of MYH7 gene at exon 14 was converted from T to G in one HCM case, resulting in the conversion of threonine (Thr) at position 446 to proline (Pro). In another case, the 1402th nucleotide at exon 14 was converted from T to C, resulting in the conversion of phenylalanine (Phe) at position 468 to leucine (Leu). Homologous comparison results showed that the two amino acid residues of Thr446 and Phe468 are highly conserved among different species.
Conclusions:
Our results showed fatal HCM harbored mutations of Thr446Pro and Phe468Leu in the MYH7 gene. It is significant for clinical and forensic medicine to further explore the functions and detailed mechanisms of these mutations.
Study Protocol
开放获取
中国急性呼吸窘迫综合征患者急性肺心病的横断面研究Long-Xiang Su, Xiu-Ling Shang, Ran Zhu, Wei He, Pan Pan, Hong-Min Zhang, Li-Na Zhang, Da-Wei Liu, Rong-Guo Yu, Xiao-Ting Wang
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000531
摘要
Background:
Increased right ventricle afterload during acute respiratory distress syndrome (ARDS) may induce acute cor pulmonale(ACP), which is associated with a poor clinical outcome. Echocardiography is now considered as a rapid and non-invasive tool for diagnosis of ACP. The aims of this study were to investigate the morbidity and mortality rates of ACP in ARDS patients in intensive care units (ICUs) across the mainland of China and to determine the severity and prognosis of ACP in ARDS patients through an ultrasound protocol (TRIP). And the association between ACP related factors and the ICU mortality will be revealed.
Methods:
This study is a multicenter and cross-sectional study in China which will include ICU participants when diagnosed as ARDS. The ultrasound protocol, known as the TRIP, is proposed as severity assessment for ACP, which includes tricuspid regurgitation velocity (T), right ventricular size (R), inferior vena cava diameter fluctuation (I), and pulmonary regurgitation velocity(P). The 28-day mortality, ICU/hospital mortality, the length of stay in ICU, mechanical ventilation days, hemodynamic parameters and lab parameters of liver function and kidney function are all recorded.
Discussion:
This large-scale study would give a sufficient epidemic investigation of ACP in ARDS patients in China. In addition, with the TRIP protocol, we expect that we could stratify ACP with more echocardiography parameters.
Trial registration:
NCT03827863, https://clinicaltrials.gov/ct2/show/NCT03827863
Review Article
开放获取
药物诱导的抗中性粒细胞胞浆抗体相关性血管炎Cheng-Hua Weng, Zhi-Chun Liu
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000539
摘要
Objective:
In recent years, an increasing number of drugs have been proved to be associated with the induction of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This article reviews the latest research progress on drug-induced AAV. Data sources: We conducted a comprehensive and detailed search of the PubMed database. The search terms mainly included druginduced, ANCA, and vasculitis.
Study selection:
We summarized the original articles and reviews on drug-induced AAV in recent years. The extracted information included the definition, epidemiology, associated drugs, pathogenesis, clinical features, diagnosis, treatment, and prognosis of druginduced AAV. We also focused on the differences between drug-induced AAV and primary vasculitis.
Results:
The offending drugs leading to drug-induced AAV are almost from pharmacologic categories and we need to be vigilant when using these drugs. The pathogenesis of drug-induced AAV might be multifactorial. The formation of neutrophil extracellular traps is an important mechanism for the development of drug-induced AAV. The clinical features of drug-induced AAV are similar to those of primary AAV. Understanding the difference between drug-induced AAV and primary AAV is helpful to identify druginduced AAV. Stopping the offending drug at once after diagnosis may be sufficient for those patients with mild symptoms. Immunosuppressive therapy should only be used in patients with vital organs involvement.
Conclusions:
Patients with drug-induced AAV usually have a good prognosis if they stop using the offending drug immediately. Recent advances in research on AAV are expected to help us better understand the pathogenesis of drug-induced AAV.
开放获取
成人型斯蒂尔病的发病机制、病程和预后：进展与综述Meng-Yan Wang, Jin-Chao Jia, Cheng-De Yang, Qiong-Yi Hu
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000538
摘要
Objective:
Adult-onset Still’s disease (AOSD) is a rare but clinically well-known polygenic systemic autoinflammatory disease. In this review, we aim to present frontiers in the pathogenesis, clinical features, diagnosis, biomarkers, disease course, prognosis, and treatment in AOSD.
Data sources:
We retrieved information from the PubMed database up to July 2019, using various search terms and relevant words, including AOSD and Still’s disease.
Study selection:
We included data from peer-reviewed journals. Both basic and clinical studies were selected.
Results:
Pathogenesis of AOSD involves genetic background, infectious triggers, and immunopathogenesis, mainly the activation of macrophages and neutrophils followed by a cytokine storm. Diagnosis and prognosis evaluation of AOSD is still challenging; therefore, there is an urgent need to identify better biomarkers. Biologic agents, including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α antagonists in the treatment of AOSD, have good prospect.
Conclusion:
This review highlights the advances in pathogenesis, potential biomarkers, disease course, and treatment in AOSD.
开放获取
系统性硬化症心脏并发症的早期诊断和治疗Liu-Yan Nie, Xiao-Dong Wang, Ting Zhang, Jing Xue
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000535
摘要
Objective:
Systemic sclerosis (SSc) is a remarkably systemic heterogeneous connective tissue disease with many organs involved. The heart is one of the major organs involved, carrying the threat of sudden cardiac death, especially in diffuse cutaneous SSc. This review summarizes the pathophysiology, types, new diagnostic approaches, and imaging and novel therapies of primary cardiac complications while underlining the effects of recently developed non-contrast cardiovascular magnetic resonance (CMR) in early diagnosis.
Data sources:
Medline and Embase were searched for articles published up to July 2019. A combination of Medical Subject Headings (MeSH) terms and keywords pertaining to SSc ( "Scleroderma, Systemic" OR "Systemic sclerosis" OR" SSc" ), AND cardiology ( "cardiology" OR "heart" OR "cardiac" ) were applied to the search strategies.
Study selection:
Literature was mainly printed in English and Chinese about cardiac complications in systemic sclerosis. After selected simply on the title and abstract, the articles were included for the full text. Article type was not limited.
Results:
Relevant cardiac manifestations are complex, including arrhythmias, pericardial effusion, myocardial dysfunction, and valvular diseases. Even though the symptoms of cardiac complications are well known, unfortunately, they appear to be poor prognostic factors. As systemic sclerosis with cardiac complications has a high mortality rate and patients might have a poor quality of life, it is essential to promote early diagnosis and treatment. With the advent of non-invasive imaging techniques, such as CMR, early diagnosis of cardiac complications in SSc is becoming more effective.
Conclusions:
Cardiac complications play an essential role in SSc and carry the threat of sudden cardiac death. More basic and clinical studies are warranted to develop better management of cardiac involvement in patients with SSc.
开放获取
硫化氢参与肾纤维化的进展Yu Wang, Qi-Qi Xing, Jing-Ke Tu, Wen-Bin Tang, Xiang-Ning Yuan, Yan-Yun Xie, Wei Wang, Zhang-Zhe Peng, Ling Huang, Hui Xu 等
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000537
摘要
Objective:
Renal fibrosis is the most common manifestation of chronic kidney disease (CKD). Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it, there is an urgent need to identify novel therapies. Hydrogen sulfide(H2S) is a newly discovered endogenous small gas signaling molecule exerting a wide range of biologic actions in our body. This review illustrates recent experimental findings on the mechanisms underlying the therapeutic effects of H2S against renal fibrosis and highlights its potential in future clinical application.
Data sources:
Literature was collected from PubMed until February 2019, using the search terms including "Hydrogen sulfide," "Chronic kidney disease," "Renal interstitial fibrosis," "Kidney disease," "Inflammation factor," "Oxidative stress," "Epithelialto-mesenchymal transition," "H2S donor," "Hypertensive kidney dysfunction," "Myofibroblasts," "Vascular remodeling," "transforming growth factor (TGF)-beta/Smads signaling," and "Sulfate potassium channels."
Study selection:
Literature was mainly derived from English articles or articles that could be obtained with English abstracts. Article type was not limited. References were also identified from the bibliographies of identified articles and the authors’ files.
Results:
The experimental data confirmed that H2S is widely involved in various renal pathologies by suppressing inflammation and oxidative stress, inhibiting the activation of fibrosis-related cells and their cytokine expression, ameliorating vascular remodeling and high blood pressure, stimulating tubular cell regeneration, as well as reducing apoptosis, autophagy, and hypertrophy. Therefore, H2S represents an alternative or additional therapeutic approach for renal fibrosis.
Conclusions:
We postulate that H2S may delay the occurrence and progress of renal fibrosis, thus protecting renal function. Further experiments are required to explore the precise role of H2S in renal fibrosis and its application in clinical treatment.
Clinical Observation
开放获取
中国特应性皮炎患者对金属和防腐剂接触性超敏反应的高患病率Fen Peng, Robert A. Schwartz, Zhou Chen, Jian-Zhong Zhang
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000526
摘要
特应性皮炎（AD）是一种以慢性复发性皮炎伴深度瘙痒为特征的炎症性皮肤病。大多数患者有特应性疾病的个人和/或家族史。[
Correspondence
开放获取
一期全髋关节置换术和“灯泡”术治疗不同时期双侧非创伤性股骨头坏死Pei Liu, Qi-Dong Zhang, Yang Wang, Zi-Qi Xia, Fei-Fan Lu, Zhao-Hui Liu, Wei-Guo Wang, Wan-Shou Guo
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000545
摘要
致编辑：临床上，双侧非创伤性股骨头坏死（NONFH）患者首次向骨科医生就诊时，一个髋关节需要全髋关节置换术（THA），另一个无症状或症状较轻的髋关节可能需要髋关节保留手术，这种情况并不罕见。理论上，要保留的髋关节应该在THA侧之前或至少与THA侧同时进行治疗。然而，一些患者可能会拒绝治疗无症状或症状较少的一侧，因为他们怀疑接受手术的必要性或担心其安全性。我们假设一个髋关节的一期THA和对侧的对侧“灯泡”手术可以为这些患者带来益处。
开放获取
肝泡状棘球蚴病所致慢性布加综合征左三段式切除及肝上腔静脉假体重建Bo Ran, Tie-Min Jiang, Aimaiti Yasen, Abudusalamu Aini, Qiang Guo, Rui-Qing Zhang, Ying-Mei Shao, Hao Wen, Aji Tuerganaili
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000521
摘要
致编辑：肝泡状棘球蚴病(AE)是一种由幼虫期引起的致死性传染病多房棘球蚴（E.multilocularis）并且在发病率和死亡率高的流行地区表现出低患病率。[
开放获取
阿达木单抗治疗极早发性炎症性肠病Yao Xie, Li-Li Liu, Yi Jiang, Ze-Zhong Tang, Guo-Yu Sun, Xin-Lin Hou
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000528
摘要
致编辑：炎症性肠病（IBD）的发病率近年来一直在增加；然而，新生儿IBD伴IL10-RA基因突变是罕见的，具有巨大的治疗挑战。在此，我们报告了一例极早发性炎症性肠病（VEO-IBD）IL-10RA阿达木单抗有效治疗的基因突变。
开放获取
抗逆转录病毒治疗依从性水平预测Arba Minch总医院接受抗逆转录病毒治疗的成年HIV感染者病毒载量抑制的时间Sultan Hussen, Mohammedaman Mama, Bitewu Mekonnen, Manaye Yihun, Mulugeta Shegaze, Negussie Boti, Mohammed Shure, Kabtamu Tolossie
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000519
摘要
致编辑：向所有有需要的人类免疫缺陷病毒（艾滋病毒）感染者提供抗逆转录病毒药物是全球卫生优先事项。在HIV患者中启动抗逆转录病毒治疗（ART）的主要目标是抑制HIV病毒复制和恢复免疫功能。[
开放获取
掺钕钇铝石榴石激光治疗睫状体复发伴眩光Li-Yang Zhou, Tian-Rui He, Ji-Bo Zhou
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000546
摘要
致编辑：我们报告了一位睫状体囊肿和眩光患者接受了掺钕钇铝石榴石激光治疗。患者主诉初次治疗3年后左眼复发性眩光。[
开放获取
5G将驱动健康医疗发展Er-Liang Li, Wen-Ji Wang
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000534
摘要
致编辑：随着中美贸易战的打响，特朗普政府签署了2019财年国防授权法案，限制华为等公司在美国使用5G。这显然与全球一体化背道而驰。5G网络综合性能高达4G的100倍，具有超高数据速率、低时延、高移动性、高能效等特点。[
开放获取
倾听人类Massimiliano Polastri
中华医学杂志英文版2019年 132卷 23期
DOI: 10.1097/CM9.0000000000000512
摘要
致编辑：艺术是任何一种人类经验的表达[
本期目次
下载本期封面 下载本期目录
